Eva Swahn

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

The Human SepSecS-tRNA ^Sec Complex Reveals the Mechanism of Selenocysteine Formation

Identifying women with severe angiographic coronary disease

A comparison of recombinant Hirudin with Heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators

Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score

Hallmarks of Cancer: The Next Generation

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Acute Coronary Care in the Elderly, Part I

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

Clopidogrel with or without Omeprazole in Coronary Artery Disease

Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

Application of the TIMI Risk Score for Unstable Angina and Non‐ST Elevation Acute Coronary Syndrome to an Unselected Emergency Department Chest Pain Population

How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?

Coronary microvascular dysfunction in the clinical setting: from mystery to reality

Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes

Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes

Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome

Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study 2b/3a upstream therapy and acute coronary syndromes

Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Identifying Acute Coronary Syndrome Patients Approaching End-of-Life

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non–ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature

Perioperative Management of Antithrombotic Therapy

Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol

Regulatory T Cells in Cancer

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction<SUBTITLE>Results From a Randomized Trial</SUBTITLE>

Evolution in Cardiovascular Care for Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb11Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON-A); Global Use of Strategies To Open occluded arteries in acute coronary syndromes (GUSTO-IIb).

Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP)

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

Selenium and human health

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Acute myocardial infarction

Unstable Angina Pectoris

ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article

Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain — An evaluation with respect to the Universal Definition of Myocardial Infarction

TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram

Recent Trends in the Care of Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction

Benefit of an Early Invasive Management Strategy in Women With Acute Coronary Syndromes

Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.

Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes

Sex and gender: modifiers of health, disease, and medicine

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

The importance of selenium to human health

Platelet Activation and Atherothrombosis

The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial

Women with acute coronary syndrome are less invasively examined and subsequently less treated than men

Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials

Frailty Assessment in the Cardiovascular Care of Older Adults

Bladder cancer

Current concepts on coronary revascularization in diabetic patients

The Year in Non–ST-Segment Elevation Acute Coronary Syndrome

Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome

Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era

Antithrombotic Therapy in the Elderly

Heparin and Low-Molecular-Weight Heparin

Association of prior coronary artery bypass graft surgery with quality of care of patients with non–ST-segment elevation myocardial infarction: A report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines

Benefit of Early Invasive Therapy in Acute Coronary Syndromes

Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes

A dose-finding study of fondaparinux in patients with non–ST-segment elevation acute coronary syndromes

Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.

The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Atherosclerosis — An Inflammatory Disease

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non–ST-elevation acute coronary syndromes

V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study

Improving Primary Care for Patients With Chronic Illness

Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease

Use of Invasive Strategy in Non–ST-Segment Elevation Myocardial Infarction Is a Major Determinant of Improved Long-Term Survival

Women do have an improved long-term outcome after non–ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

New Risk Score for Patients With Acute Chest Pain, Non-ST-Segment Deviation, and Normal Troponin Concentrations

Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb

Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Prolonged Beneficial Effects of a Home-Based Intervention on Unplanned Readmissions and Mortality Among Patients With Congestive Heart Failure

Will the Universal Definition of Myocardial Infarction Criteria Result in an Overdiagnosis of Myocardial Infarction?

Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays

Early angioplasty in acute coronary syndromes without persistent st-segment elevation improves outcome but increases the need for six-month repeat revascularization

Gender-specific ambulance priority and delays to primary percutaneous coronary intervention: A consequence of the patients' presentation or the management at the emergency medical communications center?

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial

Cardiac Magnetic Resonance With Edema Imaging Identifies Myocardium at Risk and Predicts Worse Outcome in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Women and Ischemic Heart Disease

The feasibility and safety of routine thrombus aspiration in patients with non‐ST‐elevation myocardial infarction

Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry

Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes

Efficacy of Unfractionated Heparin, Low Molecular Weight Heparin and Both Combined for Releasing Total and Free Tissue Factor Pathway Inhibitor

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

Biomarkers in Heart Failure

Risk Stratification in the Setting of Non-ST Elevation Acute Coronary Syndromes 1999-2007

Chronic Kidney Disease

Hemorrhagic Complications of Anticoagulant Treatment

Randomized Trial of Low Molecular Weight Heparin (Dalteparin) in Prevention of Left Ventricular Thrombus Formation and Arterial Embolism After Acute Anterior Myocardial Infarction: The Fragmin in Acute Myocardial Infarction (FRAMI) Study 11This study was supported by grants from the Norwegian Council on Cardiovascular Diseases, Oslo, Norway and Pharmacia AB, Stockholm, Sweden.

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes

Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study

Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis

Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes

Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability

Open Multicentre Study of the P 2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes

Markers of Inflammation and Cardiovascular Disease

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization

Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease

Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease

Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Pretreatment with P2Y ₁₂ Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Acute Myocardial Infarction in Women

Pharmacological and surgical treatment of obesity.

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes

Acute Coronary Syndromes

Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery Disease

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Inflammation and Atherosclerosis

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina

Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease

ACC/AHA 2002 guideline update for exercise testing: summary article

2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations

Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry

Application of the TIMI Risk Score for Unstable Angina and Non-ST Elevation Acute Coronary Syndrome to an Unselected Emergency Department Chest Pain Population

The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes

Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease

Fine-Particulate Air Pollution and Life Expectancy in the United States

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

Reactive Oxygen Species (ROS)-Based Nanomedicine

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Endothelial Function Predicts Future Development of Coronary Artery Disease

Patient–physician gender concordance and increased mortality among female heart attack patients

Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes

Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study

Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes

Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Sex-Specific Chest Pain Characteristics in the Early Diagnosis of Acute Myocardial Infarction

Clopidogrel Response Variability and Future Therapies

Characterization of Mammalian Selenoproteomes

Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Oral Delivery of Anticoagulant Doses of Heparin

Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Tolerance and safety of cangrelor, a novel purin receptor antagonist, used as a platelet aggregation inhibitor in the acute coronary syndrome

Coronary angiography in relation to troponin T level in patients with unstable coronary artery disease a FRISC-II substudy.

Better outcome after 2 years with an early invasive strategy in unstable coronary artery disease (UCAD) - FRISCII 2 year follow-up.

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

Gender differences in management and outcome in non-ST-elevation acute coronary syndrome

Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population

The care of patients with ischaemic heart disease from a gender perspective

Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials

NK cell apoptosis in coronary artery disease

Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease

Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction

Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)

A gender perspective on short- and long term mortality in ST-elevation myocardial infarction — A report from the SWEDEHEART register

Low molecular weight heparin (dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction—a pilot study: Biochemical Markers in Acute Coronary Syndromes (BIOMACS II)

Factors related to delay times in patients with suspected acute myocardial infarction

Plasma fibrinogen in unstable coronary artery disease

Risk stratification by early exercise testing after an episode of unstable coronary artery disease

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?

Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non—Q-wave myocardial infarction

Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction?

Risk prediction in chest pain patients by biochemical markers including estimates of renal function

Impact of an invasive strategy on 5 years outcome in men and women with non–ST-segment elevation acute coronary syndromes

Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial

Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: Effect on myocardial ischemia and need for coronary revascularization

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

Prognostic importance of early exercise testing in men with suspected unstable coronary artery disease

Troponin T‐values provide long‐term prognosis in elderly patients undergoing non‐cardiac surgery

Time trends in STEMI—improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register

Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes

ST-changes in ECG at rest or during exercise indicate a high risk of severe coronary lesions after an episode of unstable coronary artery disease

An Invasive or Conservative Strategy in Patients With Diabetes Mellitus and Non–ST-Segment Elevation Acute Coronary Syndromes

To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial

Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction

Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non–ST-Segment Elevation Myocardial Infarction

Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials

Predictive importance of clinical findings and a predischarge exercise test in patients with suspected unstable coronary artery disease